Messenger RNA expression and immunological quantification of phospholamban and SR-Ca2+-ATPase in failing and nonfailing human hearts

Cardiovascular Research

Volumn 31, Issue 4, 1996, Pages 625-632

  Linck, Bettina ^a   Bokník, Peter ^a,d   Eschenhagen, Thomas ^b   Müller, Frank U ^a   Neumann, Joachim ^a   Nose, Monika ^b   Jones, Larry R ^c   Schmitz, Wilhelm ^a   Scholz, Hasso ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Kat Farmakoiógie a Toxikol   (Slovakia)

Author keywords

Cardiomyopathy; Heart failure; Human, ventricle; Phospholamban; Signal transduction; SR Ca ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); MESSENGER RNA; PHOSPHOLAMBAN;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEART FAILURE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ADULT; AUTORADIOGRAPHY; BASE SEQUENCE; BLOTTING, NORTHERN; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHY, DILATED; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYOCARDIUM; RNA, MESSENGER;

EID: 85047669725     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(95)00236-7     Document Type: Article

References (35)

1. Morgan JP. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 1991;325: 625-632.
2. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-211.
3. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C. Increase of the 40,000 mol wt. pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 1988;82:189-197.
4. i-proteins in heart failure. Lancet 1988;2:936-937.
5. Danielsen W, von der Leyen H, Meyer W, Neumann J, Schmitz W, Scholz H, Starbatly J, Stein B, Döring V, Kalmár P. Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharm 1989;14:171-173.
6. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 1987;61:70-76.
7. Limas CJ, Olivari MT, Goldenberg IF, Levine TB, Benditt DG, Simon A. Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 1987;21:601-605.
8. Movsesian MA, Bristow MR, Krall J. Calcium uptake by cardiac sarcoplasmic reticulum from patients with dilated cardiomyopathy. Circ Res 1989;65:1141-1144.
9. 2+ uptake in cardiac sarcoplasmic reticulum from normal and failing human hearts. J Clin Invest 1990;85:1698-1702.
10. Jones LR. Sarcolemmal enzymes mediating β-adrenergic effects on the heart. In: Bronner FA, Shamoo AE (eds) Current Topics in Membranes and Transport; Regulation of Calcium Transport across Muscle Membranes. New York: Academic Press, 1985:11-41.
11. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, Doetschman T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-adrenergic stimulation. Circ Res 1994;75:401-409.
12. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart. Quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 1991;83: 1866-1872.
13. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 1990;85:305-309.
14. Arai M, Alpert NR, MacLennan DH, Barton P, Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 1992;72:463-469.
15. 2+ exchanger in end-stage human heart failure. Circ Res 1994;75:443-453.
16. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
17. 2+-transporting ATPase, phospholamban and calsequestrin levels in nonfailing and failing human heart. Circulation 1994;90:653-657.
18. Bradford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
19. 4. Nature 1970;227:680-685.
20. 2+ transport in guinea pig ventricles. J Biol Chem 1985;260: 13122-13129.
21. Neumann J, Gupta RC, Schmitz W, Scholz H, Nairn AC, Watanabe AM. Evidence for isoproterenol-induced phosphorylation of phosphatase inhibitor-1 in the intact heart. Circ Res 1991;69:1450-1457.
22. 2+ transport ATPase of cardiac sarcoplasmic reticulum. J Biol Chem 1993;268:11486-11488.
23. MacDougall LK, Jones LR, Cohen PK. Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban. Eur J Biochem 1991;196:725-734.
24. Auffray C, Rougeon F. Purification of mouse immunoglobin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980;107:303-314.
25. iα2 in human end-stage heart failure. Circ Res 1992;70:688-696.
26. 2+-ATPase mRNA. FEBS 1989;249:35-41.
27. Fujii J, Zarain-Herzberg A, Willard HF, Tada M, MacLennan DH. Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6. J Biol Chem 1991;266:11669-11675.
28. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-5467.
29. oα mRNA level and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol 1992;42:773-783.
30. Chan YL, Gutell R, Noller HF, Wool IG. The nucleotide sequence of a rat 18S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18S ribosomal ribonucleic acid. J Biol Chem 1984;259:224-230.
31. Toyofuku T, Zak R. Characterization of cDNA and genomic sequences encoding chicken phospholamban. J Biol Chem 1991;266: 5375-5383.
32. Beuckelmann DJ, Näbauer M, Erdmann E. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 1992;85:1046-1055.
33. 2+-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554-564.
34. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 1989;86:2966-2970.
35. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-564.